First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Elekta AB (publ): the story is balanced — Order intake and backlog trends - leading indicator of future revenue given 12-24 month conversion cycles for capital…
★ Analysts see FY2027 revenue reaching $17.7B — +8.1% growth in a single year.
What Moves the Stock
1Order intake and backlog trends - leading indicator of future revenue given 12-24 month conversion cycles for capital equipment
2Service contract renewal rates and installed base growth - drives recurring revenue visibility and customer lifetime value
3Gross margin trajectory - mix shift between equipment (lower margin) and software/services (higher margin) significantly impacts profitability
4Competitive win rates against Varian/Siemens in key markets - particularly North America where Elekta has historically underperformed
5Healthcare capital spending budgets in major markets - hospital purchasing cycles heavily influenced by government reimbursement policies and regional healthcare infrastructure investment
6Linear accelerator systems and treatment planning software (estimated 50-55% of revenue) - capital equipment sales with 12-24 month sales cycles
7Service contracts and aftermarket support (estimated 35-40% of revenue) - recurring revenue from installed base maintenance
8Software solutions and upgrades (estimated 10-15% of revenue) - oncology information systems and treatment planning tools
value - Trading at 1.2x sales with 43.8% FCF yield suggests deep value opportunity…
Rising rates create moderate headwinds through two channels: (1) hospital financing costs for capital equipment purchases increase…
Watch on earnings: Global healthcare capital expenditure trends - hospital equipment spending budgets by region, Cancer incidence rates and treatment capacity gaps - long-term demand driver for radiation therapy infrastructure, Varian/Siemens market share data in North America - competitive positioning in largest market.
One Sentence Summary:
Elekta AB (publ): the story is balanced — order intake and backlog trends - leading indicator of future revenue given 12-24 month conversion cycles for capital equipment.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.